Does Ocular's Latest CRL Mean A Minor Delay For Dextenza, Or A New NDA?
The biotech sought a three-month action date extension with new manufacturing process data submitted to FDA just one day before the complete response letter.
The biotech sought a three-month action date extension with new manufacturing process data submitted to FDA just one day before the complete response letter.